Valued at $489.0M at its later-stage round, Jan 2025. Nothing has traded since.
- ·Watch Rivus Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Rivus Pharmaceuticals funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Later Stage VC | $57.0M | ▮ | ▮ |
| Aug 2024 | Later Stage VC | $66.0M | ▮ | ▮ |
| Aug 2022 | Early Stage VC (Series B) | $132.0M | ▮ | ▮ |
| Mar 2019 | Early Stage VC | $34.5M | ▮ | ▮ |
Membership and data by Private Market View
Rivus Pharmaceuticals valuation
Rivus Pharmaceuticals was valued at $489 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Rivus Pharmaceuticals raised?
Rivus Pharmaceuticals has raised $224 million across 4 recorded rounds since 2019. The largest was a $66 million later-stage round in Aug 2024; the most recent was a $57 million later-stage round in Jan 2025.
Rivus Pharmaceuticals has filed 4 Form Ds with the SEC since 2021, most recently in Jan 2025 ($57 million sold to 7 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Electra Therapeutics ($479 million), CORXEL Pharmaceuticals ($475 million) and Diagonal Therapeutics ($459 million).
How Rivus Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Rivus Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Rivus Pharmaceuticals
- What is Rivus Pharmaceuticals worth?
- Rivus Pharmaceuticals is valued at $489.0M as of Oct 2026. Valued at $489.0M at its later-stage round, Jan 2025. Nothing has traded since.
- How much has Rivus Pharmaceuticals raised?
- Rivus Pharmaceuticals has raised $224.0M in total funding across 4 recorded rounds.
- When did Rivus Pharmaceuticals last raise?
- Rivus Pharmaceuticals last raised in Jan 2025 (Later Stage VC), raising $57.0M.